In the News

1861 News Items found
Memorial Sloan Kettering exercise scientist Lee Jones
Q&A
People with prostate cancer can benefit from exercise in more ways than they might expect.
Memorial Sloan Kettering structural biologist Christopher Lima and physician-scientist Michael Glickman
In the Clinic
An antibody test developed at MSK could shed light on the immune response to the COVID-19 virus.
Regulatory proteins (gold balls) bind to enhancer regions (light blue) and promoter regions (pink) of DNA to form clusters that enable transcription (purple).
Scientists at the Sloan Kettering Institute are learning how far-flung regions of genes connect to start the process of making proteins.
Pathologist Matthew Hanna in front of a microscope
Collaboration leads to a new digital pathology tool that allows some doctors to diagnose patient tumors from home.
Piro Lito, Bob Li, and Neal Rosen in the lab
In the Clinic
The drug, sotorasib, is targeted against a cancer-causing protein that has long been considered an “undruggable” target.
ESMO 2020
MSK physicians and scientists are involved in notable research to be presented during the virtual meeting.
Nurse practitioner Emily Sarro helps coordinate care for patients in MSK’s Adolescent and Young Adult (AYA at MSK) program.
Cancer is tough, no matter the age. But adolescents and young adults with cancer face a whole host of unique challenges, including delayed diagnoses. MSK created an Adolescent and Young Adult (AYA at MSK) program which unites experts across 16 specialties.
Social Distancing
Restrictions due to COVID-19 are leaving many feeling isolated or lonely. MSK Psychologist Kelly Trevino, PhD, shares simple ways to find meaning and stay connected during this time.
MSK medical oncologist Robert Motzer
A study of nearly 900 kidney cancer tumors has identified previously unknown biomarkers that correlate with better treatment responses to immunotherapy and targeted therapy.
Scanning electron microscope image of a breast cancer cell.
In the Lab
A new finding provides insight into how breast cancer develops resistance to aromatase inhibitors.